Khalid Alsulaiman Shared a New Study About Clinical Outcomes of Apixaban
Khalid Alsulaiman, Vice Chairman, Clinical Trial Management (CTM) at King Abdullah International Medical Research Center, shared a post on LinkedIn:
“Happy to share our new study titled: “*Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence*”, published in Clinical and Applied Thrombosis/Hemostasis.
In this study, we evaluated the effectiveness and safety of apixaban among patients with atrial fibrillation who also suffer from uncontrolled hypothyroidism. Our findings indicate that the use of apixaban in patients with AF and uncontrolled hypothyroidism was linked to higher rates of thrombosis and major bleeding compared to those without known hypothyroidism. These findings highlight the need for further research through larger prospective studies in this often-overlooked population.
We would like to thank all investigators who contributed to this project from the Saudi Critical Care Pharmacy Research (SCAPE) Platform, Saudi Society for Multidisciplinary Research Development and Education (SCAPE Society) and King Abdullah International Medical Research Center (كيمارك KAIMRC).”
Title: Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence
Authors: Khalid Al Sulaiman, Manal A Aljohani, Abdullah F Alharthi, Hisham A Badreldin, Mohammed Y Alzahrani, Rahaf A Alqahtani, Walaa A Alshahrani, Fatimah M Abudayah, Mohammad S Shawaqfeh, Ahmed A Alrashed, Alaa M Alenazi, Nouf S Alsagri, Mohammed Yahya Asiri, Zayed Asiri, Sulaiman Aljarallah, Yusuf M. Garwan, Lama S. Alfehaid, Abeer A. Alenazi, Tariq Aldebasi, Shmeylan Alharbi, Ahmed Aldemerdash, Amer Alzahrani, Ohoud Aljuhani
Read full article here.
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear